Skip to main content

and
  1. No Access

    Article

    Kee** ILCs in shape: PD-1 as a metabolic checkpoint

    Anti-PD-1 immunotherapy has emerged as a revolutionary therapeutic strategy against cancer. However, it often leads to undesired side effects. In this issue, a new study reports how PD-1 signalling drives meta...

    Laura Surace, Christoph Wilhelm in Nature Metabolism (2022)